| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2113435 | Cancer Letters | 2012 | 11 Pages |
Abstract
Seeking to improve ovarian cancer therapy, we compared biological characteristics of the moderately-aggressive OVCAR-3 cell line with two highly aggressive ovarian cancer cell populations: the SK-OV-3 cell line, and HASCJ primary cells isolated from the ascitic fluid of a patient with FIGO stage IV ovarian cancer. Secretion of angiogenic factors was not discriminative, whereas cell invasion through Matrigel and vasculogenic mimicry were much greater in the more aggressive cells. Among 10 agents tested for their ability to decrease cancer cell aggressivity using these two models, inhibitors of Stat3, IGF-IR and Rho GTPase were found to be the most promising.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Caroline Gest, Pezhman Mirshahi, Hong Li, Linda-Louise Pritchard, Ulrich Joimel, Emmanuel Blot, Jean Chidiac, Bernard Poletto, Jean-Pierre Vannier, Remi Varin, Massoud Mirshahi, Lionel Cazin, Eric Pujade-Lauraine, Jeannette Soria, Claudine Soria,